Format: Recorded Webinar
CE Credits available until: March 9, 2021
Target Audience
Oncology nurses and social workers and other healthcare professionals involved in the care of patients with hematologic malignancies.
Course content level: Intermediate and Advanced
Description
This webinar will provide a basic overview of high-risk MDS and secondary AML, focusing on strategies for patient management. Risk assessment, treatment options, the role of various members of the healthcare team in addressing treatment goals, guidance for patients and caregivers in treatment decision making, as well as resources for patients and caregivers will be discussed.
Learning Objectives
At the conclusion of this program, participants will be able to:
- Describe a management strategy for high-risk MDS/AML based on clinical presentation, diagnostic workup and recent research findings
- Explain the role of genetic testing in risk assessment and stratification for patients
- Identify emerging treatment options for high-risk MDS and secondary AML
- Discuss the roles of a multidisciplinary healthcare team in addressing treatment goals and providing patient education to improve outcomes, including guiding patients and caregivers in decision making, financial issues, and palliative care options
- Identify resources for support and education for patients
Speakers
Naveen Pemmaraju, MD
Associate Professor
Department of Leukemia
MD Anderson Cancer Center
Houston, TX
Allyson Price, MPAS, PA-C
Physician Assistant
Department of Leukemia
MD Anderson Cancer Center
Houston, TX
Michelle Rajotte, LMSW
Associate Director
Information Resource Center
The Leukemia & Lymphoma Society
Rye Brook, NY
Continuing Education
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 1.0 continuing education contact hours through the California Board of Registered Nursing.
The Leukemia & Lymphoma Society (LLS) Provider Number 1105, is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved as ACE providers. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. LLS maintains responsibility for this course. ACE provider approval period: 12/10/17-12/14/2020. Social workers completing this course receive 1.0 continuing education credit.
The Leukemia & Lymphoma Society (LLS) is recognized by the New York State Education Departments State Board for Social Work as an approved provider of continuing education for licensed social workers #0117. LLS maintains responsibility for the program. Social workers will receive 1.0 clinical CE contact hours for this activity.
Participants must attend the free webinar in its entirety and submit the online evaluation form to earn credit. Once submitted, the certificate will be automatically generated as a PDF online.
Providers
This program is provided by The Leukemia & Lymphoma Society and the Aplastic Anemia & MDS International Foundation.
Participants gain access to the webinar via the registration button above.
For questions, concerns, or for assistance for people with disabilities or grievances, please contact: Caroline.Kornhauser@LLS.org or 914-821-8420.
< Back to Continuing Education